Key Segmentation
By Product Type
-
Dried Blood Spot (DBS) Cards
-
FTA (Flinders Technology Associates) Cards
-
Guthrie Cards (Neonatal Screening Cards)
-
Protein Saver Cards
-
Others
By Application
-
Newborn Screening
-
Infectious Disease Testing
-
Forensic & DNA Analysis
-
Therapeutic Drug Monitoring
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Research & Academic Institutes
-
Forensic Laboratories
-
Blood Banks
By Sample Type
-
Blood Samples
-
Saliva Samples
-
Buccal Swabs
-
Other Biological Samples
By Distribution Channel
-
Direct Sales
-
Distributors & Suppliers
-
Online Channels
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with a 35.84% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 6.63% during 2026–2035.
Dried Blood Spot (DBS) Cards dominated with a 46.25% share in 2025, while Protein Saver Cards are projected to grow at the fastest CAGR of 7.06% during 2026–2035.
Growth is driven by rising adoption of decentralized diagnostics and newborn screening programs, along with increasing demand for cost-effective, stable, and easy-to-transport biological sample collection solutions.
The market is valued at USD 481.32 Million in 2025 and is projected to reach USD 805.41 Million by 2035.
The Specimen Collection Cards Market is projected to grow at a CAGR of 5.37% during 2026–2035.